Evidence map›Paper›PMID 31312384›Full record

ArticleAmerican journal of translational research2019

Therapy of

Fuhong Dai, Jiangye Wang, Hongshan An, Ting Lei, Ke Tang, Xiaochun Ma, Peng Duo, Pengyun Ren, Wenxiao Chai

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Lentinan Combined with (125)I Brachytherapy for Recurrent Ovarian Cancer.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  10. Article
  11. Evaluation of radioactiveBMC cancer · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Fuhong DaiDepartment of Interventional Oncology, Gansu Provincial Hospital Lanzhou, Gansu, China.
Jiangye WangDepartment of Interventional Oncology, Gansu Provincial Hospital Lanzhou, Gansu, China.
Hongshan AnDepartment of Interventional Therapy, Tianzhu County People's Hospital Tianzhu, Gansu, China.
Ting LeiDepartment of Reproductive Center, Minle County Maternity and Child-Care Hospital Minle, Gansu, China.
Ke TangDepartment of Medical Imaging, Linxia State Hospital Linxia, Gansu, China.
Xiaochun MaDepartment of Radiotherapy, Gansu Provincial Hospital Lanzhou, Gansu, China.
Peng DuoSecond Department of Surgery, Minle County Chinese Medicine Hospital Minle, Gansu, China.
Pengyun RenDepartment of Interventional Therapy, Minle County Chinese Medicine Hospital Minle, Gansu, China.
Wenxiao ChaiDepartment of Interventional Oncology, Gansu Provincial Hospital Lanzhou, Gansu, China.
Gansu Provincial Hospital · CNGävle Hospital · SEGansu Provincial Maternal and Child Health Hospital · CNThe First People's Hospital of Tianmen · CNThe People's Hospital of LinXia · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to investigate the efficacy and safety of

methodsData from 56 patients with advanced NSCLC between January 2013 and May 2016 were retrospectively analyzed. The changes of tumor size, objective response rate (ORR), disease control rate (DCR), survival rate of patients and occurrence rate of complications were calculated, and the levels of carcinoembryonic antigen (CEA) and cytokerantin-19-fragment (CYFRA21-1) before and after the treatment were evaluated.

resultsThe

conclusionsNSCLC patients at different clinical features all can benefit from the

Indexed as

125I particles implantationcarcinoembryonic antigenefficacyiodine-125Non-small cell lung cancer

Identifiers

PMID31312384
PMCPMC6614640
OpenAlexW3021088607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.